1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes

BackgroundType 1 diabetes is associated with more severe glycemic variability and more frequent hypoglycemia than type 2 diabetes. Glycemic variability is associated with poor glycemic control and diabetic complications. In this study, we demonstrate the clinical usefulness of serum 1,5-anhydrogluci...

Full description

Bibliographic Details
Main Authors: Hannah Seok, Ji Hye Huh, Hyun Min Kim, Byung-Wan Lee, Eun Seok Kang, Hyun Chul Lee, Bong Soo Cha
Format: Article
Language:English
Published: Korean Diabetes Association 2015-04-01
Series:Diabetes & Metabolism Journal
Subjects:
Online Access:http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-164.pdf
_version_ 1811200473625001984
author Hannah Seok
Ji Hye Huh
Hyun Min Kim
Byung-Wan Lee
Eun Seok Kang
Hyun Chul Lee
Bong Soo Cha
author_facet Hannah Seok
Ji Hye Huh
Hyun Min Kim
Byung-Wan Lee
Eun Seok Kang
Hyun Chul Lee
Bong Soo Cha
author_sort Hannah Seok
collection DOAJ
description BackgroundType 1 diabetes is associated with more severe glycemic variability and more frequent hypoglycemia than type 2 diabetes. Glycemic variability is associated with poor glycemic control and diabetic complications. In this study, we demonstrate the clinical usefulness of serum 1,5-anhydroglucitol (1,5-AG) for assessing changes in glycemic excursion in type 1 diabetes.MethodsSeventeen patients with type 1 diabetes were enrolled in this study. A continuous glucose monitoring system (CGMS) was applied twice at a 2-week interval to evaluate changes in glycemic variability. The changes in serum glycemic assays, including 1,5-AG, glycated albumin and hemoglobin A1c (HbA1c), were also evaluated.ResultsMost subjects showed severe glycemic excursions, including hypoglycemia and hyperglycemia. The change in 1,5-AG level was significantly correlated with changes in the glycemic excursion indices of the standard deviation (SD), mean amplitude of glucose excursion (MAGE), lability index, mean postmeal maximum glucose, and area under the curve for glucose above 180 mg/dL (r=-0.576, -0.613, -0.600, -0.630, and -0.500, respectively; all P<0.05). Changes in glycated albumin were correlated with changes in SD and MAGE (r=0.495 and 0.517, respectively; all P<0.05). However, changes in HbA1c were not correlated with any changes in the CGMS variables.Conclusion1,5-AG may be a useful marker for the assessment of short-term changes in glycemic variability. Furthermore, 1,5-AG may have clinical implications for the evaluation and treatment of glycemic excursions in type 1 diabetes.
first_indexed 2024-04-12T02:04:50Z
format Article
id doaj.art-b674bc3a977942eaa2aec530a308dbe3
institution Directory Open Access Journal
issn 2233-6079
2233-6087
language English
last_indexed 2024-04-12T02:04:50Z
publishDate 2015-04-01
publisher Korean Diabetes Association
record_format Article
series Diabetes & Metabolism Journal
spelling doaj.art-b674bc3a977942eaa2aec530a308dbe32022-12-22T03:52:34ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872015-04-0139216417010.4093/dmj.2015.39.2.164146741,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 DiabetesHannah SeokJi Hye HuhHyun Min KimByung-Wan LeeEun Seok KangHyun Chul LeeBong Soo ChaBackgroundType 1 diabetes is associated with more severe glycemic variability and more frequent hypoglycemia than type 2 diabetes. Glycemic variability is associated with poor glycemic control and diabetic complications. In this study, we demonstrate the clinical usefulness of serum 1,5-anhydroglucitol (1,5-AG) for assessing changes in glycemic excursion in type 1 diabetes.MethodsSeventeen patients with type 1 diabetes were enrolled in this study. A continuous glucose monitoring system (CGMS) was applied twice at a 2-week interval to evaluate changes in glycemic variability. The changes in serum glycemic assays, including 1,5-AG, glycated albumin and hemoglobin A1c (HbA1c), were also evaluated.ResultsMost subjects showed severe glycemic excursions, including hypoglycemia and hyperglycemia. The change in 1,5-AG level was significantly correlated with changes in the glycemic excursion indices of the standard deviation (SD), mean amplitude of glucose excursion (MAGE), lability index, mean postmeal maximum glucose, and area under the curve for glucose above 180 mg/dL (r=-0.576, -0.613, -0.600, -0.630, and -0.500, respectively; all P<0.05). Changes in glycated albumin were correlated with changes in SD and MAGE (r=0.495 and 0.517, respectively; all P<0.05). However, changes in HbA1c were not correlated with any changes in the CGMS variables.Conclusion1,5-AG may be a useful marker for the assessment of short-term changes in glycemic variability. Furthermore, 1,5-AG may have clinical implications for the evaluation and treatment of glycemic excursions in type 1 diabetes.http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-164.pdf1,5-anhydroglucitolContinuous glucose monitoringType 1 diabetesGlycemic variability
spellingShingle Hannah Seok
Ji Hye Huh
Hyun Min Kim
Byung-Wan Lee
Eun Seok Kang
Hyun Chul Lee
Bong Soo Cha
1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
Diabetes & Metabolism Journal
1,5-anhydroglucitol
Continuous glucose monitoring
Type 1 diabetes
Glycemic variability
title 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
title_full 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
title_fullStr 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
title_full_unstemmed 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
title_short 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
title_sort 1 5 anhydroglucitol as a useful marker for assessing short term glycemic excursions in type 1 diabetes
topic 1,5-anhydroglucitol
Continuous glucose monitoring
Type 1 diabetes
Glycemic variability
url http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-164.pdf
work_keys_str_mv AT hannahseok 15anhydroglucitolasausefulmarkerforassessingshorttermglycemicexcursionsintype1diabetes
AT jihyehuh 15anhydroglucitolasausefulmarkerforassessingshorttermglycemicexcursionsintype1diabetes
AT hyunminkim 15anhydroglucitolasausefulmarkerforassessingshorttermglycemicexcursionsintype1diabetes
AT byungwanlee 15anhydroglucitolasausefulmarkerforassessingshorttermglycemicexcursionsintype1diabetes
AT eunseokkang 15anhydroglucitolasausefulmarkerforassessingshorttermglycemicexcursionsintype1diabetes
AT hyunchullee 15anhydroglucitolasausefulmarkerforassessingshorttermglycemicexcursionsintype1diabetes
AT bongsoocha 15anhydroglucitolasausefulmarkerforassessingshorttermglycemicexcursionsintype1diabetes